Xarelto gets no love from FDA panel

Deborah Weinstein

May 24 2012

Fuzzy data and missing patients led the majority of the FDA panel members to vote against allowing Bayer/J&J's drug to ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.